Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
BioServe Biotechnologies is a global provider of genomic services and molecular biology solutions, specializing in biorepository management and high-throughput genomic processing. The company maintains a massive "Global Repository" containing over 600,000 human DNA, tissue, and serum samples linked to detailed clinical data, which serves as a critical resource for biomarker discovery and drug validation. BioServe provides a comprehensive suite of services including DNA/RNA extraction, genotyping, sequencing, and gene expression analysis to pharmaceutical and biotechnology partners. Since its acquisition by REPROCELL, the company has integrated its genomic capabilities with stem cell technologies to support personalized medicine and advanced preclinical research.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on BioServe Technologies.